SUSMED,Inc. (4263.T)

JPY 579.0

(-1.03%)

Annual Income Statements

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Revenue 342.57 Million 530.65 Million 316.87 Million 115.48 Million 34.88 Million
Cost of Revenue 11.72 Million 7.98 Million 10.37 Million 9.76 Million 1.55 Million
Gross Profit 330.85 Million 522.66 Million 306.49 Million 105.72 Million 33.33 Million
Operating Expenses 695.83 Million 570.98 Million 535.65 Million 439.14 Million 194.06 Million
Selling, General and Administrative Expenses 452.47 Million 394.67 Million 309.28 Million 190.01 Million 107.69 Million
Research and Development Expenses 243.35 Million 176.31 Million 226.36 Million 249.13 Million 86.36 Million
Other Expenses - 4.4 Million 36.01 Million 62.33 Million 71.9 Million
Cost and Expenses 707.55 Million 578.97 Million 546.02 Million 448.91 Million 195.61 Million
Operating Income -364.98 Million -48.31 Million -229.15 Million -333.42 Million -160.72 Million
Interest Expense - 407 Thousand 24.3 Million - -
Income Tax Expense 1.21 Million 1.21 Million 319 Thousand 1.84 Million 290 Thousand
Earnings before Tax -356.2 Million -49.53 Million -233.16 Million -275.71 Million -96.63 Million
Net Income -357.41 Million -50.74 Million -233.48 Million -277.55 Million -96.92 Million
Earnings Per Share Basic -21.41 -3.09 -15.90 -21.69 -6.23
Earnings Per Share Diluted -21.41 -3.09 -15.90 -21.69 -6.23
Weighted Average Shares Outstanding 16.69 Million 16.4 Million 14.68 Million 12.79 Million 15.54 Million
Weighted Average Shares Outstanding (Diluted) 16.69 Million 16.4 Million 14.68 Million 12.79 Million 15.54 Million
Gross Margin 0.97 0.98 0.97 0.92 0.96
EBIT Margin -1.05 -0.07 -0.67 -2.85 -4.38
Profit Margin -1.04 -0.10 -0.74 -2.40 -2.78
EBITDA -360 Million -43 Million -228 Million -275.59 Million -96.45 Million
Earnings Before Tax Margin -1.07 -0.09 -0.72 -2.89 -4.61

Income Statement Charts